Meanwhile, ASGR1+ tumor-associated microparticles (taMPs) are significantly elevated in the peripheral blood of patients with HCC and cholangiocarcinoma, suggesting their potential as a novel non-invasive diagnostic tool for distinguishing liver cancer from liver cirrhosis (94). This evidence concerns the gene ASGR1 and liver cancer.